Conventional Type I Migratory CD103+ Dendritic Cells are Required for Corneal Allograft Survival

Blanco T, Singh RB, Nakagawa H, Taketani Y, Dohlman T, Chen Y, Chauhan S, Yin J, Danan R. Conventional Type I Migratory CD103+ Dendritic Cells are Required for Corneal Allograft Survival. Mucosal Immunol. 2023;
See also: Cornea, January 2023, All, 2023

Abstract

Corneal transplant rejection primarily occurs due to T helper 1 (Th1) effector cell mediated immune response of the host toward allogeneic tissue. The evidence suggests that Type 1 migratory conventional CD103+ dendritic cells (CD103+DC1) acquire an immunosuppressive phenotype in the tumor environment; however, the involvement of CD103+DC1 in allograft survival continues to be an elusive question of great clinical significance in tissue transplantation. In this study, we assess the role of CD103+DC1 in suppressing Th1 alloreactivity against transplanted corneal allografts. The immunosuppressive function of CD103+DC1 has been extensively studied in non-transplantation settings. We found that host CD103+DC1 infiltrate the corneal graft and migrate to the draining lymph nodes (DLN) to suppress alloreactive CD4+ Th1 cells via the programmed death-ligand 1 (PD-L1/ PD-1) axis. The systemic depletion of CD103+ DC1 in allograft recipients leads to amplified Th1 activation, impaired Treg function, and increased frequency of allograft rejection. While allograft recipient Rag1 null mice reconstituted with naïve CD4+CD25- T cells efficiently generated peripheral Treg cells (pTreg), the CD103+DC1-depleted mice failed to generate pTreg. Furthermore, adoptive transfer of pTreg failed to rescue allografts in CD103+DC1-depleted recipients from rejection. These data demonstrate the critical role of CD103+DC1 in regulating host alloimmune responses. Short title: Role of CD103+ DCs in corneal allograft survival.
Last updated on 03/06/2023